Rocket Pharmaceuticals (RCKT) Misses Q1 EPS by 2c

Rocket Pharmaceuticals (NASDAQ: RCKT) reported Q1 EPS of ($0.42), $0.02 worse than the analyst estimate of ($0.40).

For earnings history and earnings-related data on Rocket Pharmaceuticals (RCKT) click here.

You May Also Be Interested In

• L3Harris CEO steps down amid conduct review, shares drop
• Seaport Global Securities Downgrades JetBlue Airways (JBLU) to Neutral
• DA Davidson Reiterates Buy Rating on Walmart (WMT) Ahead of Earnings